Penserra Capital Management LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$103,000
-1.9%
875
-1.7%
0.00%0.0%
Q4 2020$105,000
+191.7%
890
+171.3%
0.00%
+100.0%
Q3 2020$36,0003280.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 164,500$15,011,00010.32%
HHLR ADVISORS, LTD. 2,751,200$251,047,0006.99%
Dalton Investments, Inc. 113,851$10,389,0004.54%
Point72 Hong Kong Ltd 115,939$10,579,0004.17%
York Capital Management Global Advisors, LLC 991,233$90,450,0004.05%
RUDMAN ERROL M 58,000$5,293,0003.57%
Greenwoods Asset Management Ltd 479,580$43,762,0002.69%
Parametrica Management Ltd 3,663$334,0000.71%
Temasek Holdings (Private) Ltd 990,000$90,338,0000.62%
Athos Capital Ltd 8,290$756,0000.49%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders